Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece

BACKGROUND: To undertake an economic evaluation of rivaroxaban relative to the standard of care for stroke prevention in patients with non-valvular atrial fibrillation (AF) in Greece. METHODS: An existing Markov model designed to reflect the natural progression of AF patients through different healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Kourlaba, Georgia, Maniadakis, Nikos, Andrikopoulos, George, Vardas, Panos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942277/
https://www.ncbi.nlm.nih.gov/pubmed/24512351
http://dx.doi.org/10.1186/1478-7547-12-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942277/
https://www.ncbi.nlm.nih.gov/pubmed/24512351
http://dx.doi.org/10.1186/1478-7547-12-5

Ejemplares similares